ClinicalNews

Substitution arrangement for fluoxetine

Covid-19 OUT OF STOCK store lightbox sign showing text message for shortage of PPE medical supplies. Coronavirus panic hoarding led to sold out shelves. shortage of hand sanitizer, mask products.
Temporary approval granted for replacement oral fluoxetine product as shortage continues Due to the shortage of fluoxetine (brand name: Zactin Tablet), the Federal Department of Health has announced it has temporarily listed on the PBS an alternative brand: Fluoxetine 10 mg Capsules (Medreich, UK) from 1 February. The Therapeutic Goods Administration (TGA) has temporarily approved

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous John Coppock Pharmacist Wellbeing Award launched
Next Pharmacist unlikely to repeat conduct: tribunal

Related Posts